These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18611100)

  • 1. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain.
    Fishbain DA
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S123-8. PubMed ID: 18611100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough pain in the management of chronic persistent pain syndromes.
    Webster LR
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
    Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
    Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of breakthrough pain.
    McCarberg BH
    Pain Med; 2007; 8 Suppl 1():S8-13. PubMed ID: 17280601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
    Slatkin NE; Xie F; Messina J; Segal TJ
    J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.
    Fine PG; Narayana A; Passik SD
    Pain Med; 2010 Jul; 11(7):1024-36. PubMed ID: 20642730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
    Weinstein SM; Messina J; Xie F
    Cancer; 2009 Jun; 115(11):2571-9. PubMed ID: 19373888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain.
    Farrar JT; Messina J; Xie F; Portenoy RK
    Pain Med; 2010 Sep; 11(9):1313-27. PubMed ID: 20807345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough pain: progress in management.
    Lossignol DA; Dumitrescu C
    Curr Opin Oncol; 2010 Jul; 22(4):302-6. PubMed ID: 20489619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study.
    Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated strategies for the successful management of breakthrough cancer pain.
    Dickman A
    Curr Opin Support Palliat Care; 2011 Mar; 5(1):8-14. PubMed ID: 21325998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?
    Lecybyl R; Hanna M
    Future Oncol; 2007 Aug; 3(4):375-9. PubMed ID: 17661711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management.
    Fine PG; Mahajan G; McPherson ML
    Pain Med; 2009 Jul; 10 Suppl 2():S79-88. PubMed ID: 19691687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues in the management of chronic nonmalignant pain.
    Pappagallo M; Heinberg LJ
    Semin Neurol; 1997; 17(3):203-11. PubMed ID: 9311061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the pharmacokinetic profile of transmucosal fentanyl formulations.
    Moore N; Darwish M; Amores X; Schneid H
    Curr Med Res Opin; 2012 Nov; 28(11):1781-90. PubMed ID: 23020252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current developments in opioid therapy for management of cancer pain.
    de Leon-Casasola OA
    Clin J Pain; 2008 May; 24 Suppl 10():S3-7. PubMed ID: 18418225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids for persistent noncancer pain.
    McCleane G; Smith HS
    Anesthesiol Clin; 2007 Dec; 25(4):787-807, vi-ii. PubMed ID: 18054145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse.
    Manchikanti L; Singh V; Caraway DL; Benyamin RM
    Pain Physician; 2011; 14(2):E103-17. PubMed ID: 21412376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids for management of breakthrough pain in cancer patients.
    Potter MB
    Am Fam Physician; 2006 Dec; 74(11):1855-7. PubMed ID: 17168339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.